ScholarIQanswers from OpenAlex & ORCID
Jeffrey A. Bluestone
ResearcherPublications, citations & collaboration network
Jeffrey A. Bluestone is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Jeffrey A. Bluestone have?
ScholarIQindexed works
Jeffrey A. Bluestone has 671 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Jeffrey A. Bluestone have?
ScholarIQcitation count
Jeffrey A. Bluestone has 94,537 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Jeffrey A. Bluestone?
ScholarIQh-index
Jeffrey A. Bluestone has an h-index of 159 in OpenAlex.
What is the i10-index of Jeffrey A. Bluestone?
ScholarIQi10-index
Jeffrey A. Bluestone has an i10-index of 474 in OpenAlex.
What is the ORCID of Jeffrey A. Bluestone?
ScholarIQorcid
The ORCID for Jeffrey A. Bluestone is on the source record.
What is the OpenAlex record for Jeffrey A. Bluestone?
ScholarIQopenalex
The OpenAlex for Jeffrey A. Bluestone is on the source record.
What are the most-cited papers on Jeffrey A. Bluestone?
ScholarIQmost cited works
International Trial of the Edmonton Protocol for Islet Transplantation
A. M. James Shapiro, Camillo Ricordi, Bernhard J. Hering, Hugh Auchincloss, Robert Lindblad, R. Paul Robertson, Antonio Secchi, Mathias D. Brendel, Thierry Berney, Daniel C. Brennan, Enrico Cagliero, Rodolfo Alejandro, Edmond A. Ryan, Barbara DiMercurio, Philippe Morel, Kenneth S. Polonsky, Jo-Anna Reems, Reinhard G. Bretzel, Federico Bertuzzi, Tatiana Froud, Raja Kandaswamy, David E.R. Sutherland, George S. Eisenbarth, Miriam Segal, Jutta Preiksaitis, Gregory S. Korbutt, Franca B. Barton, Lisa Viviano, Vicki Seyfert‐Margolis, Jeffrey A. Bluestone, Jonathan R. T. Lakey
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
Kevan C. Herold, Brian N. Bundy, S. Alice Long, Jeffrey A. Bluestone, Linda A. DiMeglio, Matthew J. Dufort, Stephen E. Gitelman, Peter A. Gottlieb, Jeffrey P. Krischer, Peter S. Linsley, Jennifer B. Marks, Wayne D. Moore, Antoinette Moran, Henry Rodriguez, William E. Russell, Desmond Schatz, Jay S. Skyler, Eva Tsalikian, Diane K. Wherrett, Anette-Gabriele Ziegler, Carla J. Greenbaum
Repression of the genome organizer SATB1 in regulatory T cells is required for suppressive function and inhibition of effector differentiation
Marc Beyer, Yasser Thabet, Roman‐Ulrich Müller, Timothy Sadlon, Sabine Claßen, Katharina Lahl, Samik Basu, Xuyu Zhou, Samantha L. Bailey-Bucktrout, Wolfgang Krebs, E. Schönfeld, Jan P. Böttcher, Tatiana N. Golovina, Christian T. Mayer, Andrea Hofmann, Daniel Sommer, Svenja Debey‐Pascher, Elmar Endl, Andreas Limmer, Keli L. Hippen, Bruce R. Blazar, Robert Balderas, Thomas Quast, Andreas Waha, Günter Mayer, Michael Famulok, Percy A. Knolle, Claudia Wickenhauser, Waldemar Kolanus, Bernhard Schermer, Jeffrey A. Bluestone, Simon C. Barry, Tim Sparwasser, James L. Riley, Joachim L. Schultze
Immunoregulatory functions for murine intraepithelial lymphocytes: gamma/delta T cell receptor-positive (TCR+) T cells abrogate oral tolerance, while alpha/beta TCR+ T cells provide B cell help.
Kohtaro Fujihashi, Takashi Taguchi, Wilhelm K. Aicher, Jerry R. McGhee, Jeffrey A. Bluestone, John H. Eldridge, Hiroshi Kiyono
Adoptive Treg Cell Therapy in a Patient With Systemic Lupus Erythematosus
Maria Dall’Era, Mariela Pauli, Kelly A. Remedios, Keyon Taravati, Priscila M. Sandova, Amy Putnam, Angela Lares, Anna Haemel, Qizhi Tang, Marc K. Hellerstein, Marc Fitch, James McNamara, Beverly Welch, Jeffrey A. Bluestone, David Wofsy, Michael D. Rosenblum